Effects of semaglutide in patients with type 2 diabetes and peripheral artery disease: An analysis of the STRIDE trial stratified by disease severity and age
Authors:
Joakim Nordanstig1; Ecenur G. Arslan2; Andrei-Mircea Catarig2; Kim Houlind3,4; Bernhard Ludvik5; Neda Rasouli6; Harald Sourij7; Sebastian Thomas8; Subodh Verma9; Marc P. Bonaca10
Affiliations
View DetailsHide Details
{{ getPageNum(PDFPage) }}
Share
Copy link
{{pageUrl}}
Keywords
Cardiovascular Disease
Congress oral presentation
GLP-1 RA
Semaglutide
Get notified when materials for ESC 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
Get notified when materials for ESC 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
{{ error.$message }}
Success
We will notify you when new materials become available for ESC 2025 and future congresses.
We will keep you updated in your inbox:
Subscribe to receive updates on related congresses in the same disease area: